SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000039
Filing Date
2020-06-19
Accepted
2020-06-19 17:14:02
Documents
14
Period of Report
2020-06-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K anab-20200619.htm   iXBRL 8-K 54131
  Complete submission text file 0001370053-20-000039.txt   200112

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20200619.xsd EX-101.SCH 2442
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200619_cal.xml EX-101.CAL 726
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200619_def.xml EX-101.DEF 1663
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200619_lab.xml EX-101.LAB 25298
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200619_pre.xml EX-101.PRE 13206
8 EXTRACTED XBRL INSTANCE DOCUMENT anab-20200619_htm.xml XML 10949
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 20976493
SIC: 2834 Pharmaceutical Preparations